Privia Health Group, Inc. (NASDAQ:PRVA) Director William M. Sullivan Sells 18,153 Shares

Privia Health Group, Inc. (NASDAQ:PRVAGet Rating) Director William M. Sullivan sold 18,153 shares of the company’s stock in a transaction on Friday, January 20th. The stock was sold at an average price of $25.36, for a total transaction of $460,360.08. Following the completion of the transaction, the director now directly owns 5,808,777 shares of the company’s stock, valued at $147,310,584.72. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Privia Health Group Stock Performance

Shares of PRVA stock opened at $24.82 on Wednesday. The firm’s 50-day moving average is $23.64 and its 200-day moving average is $31.38. The stock has a market cap of $2.84 billion, a price-to-earnings ratio of -68.94 and a beta of 0.67. Privia Health Group, Inc. has a 52-week low of $17.99 and a 52-week high of $44.64.

Privia Health Group (NASDAQ:PRVAGet Rating) last issued its earnings results on Thursday, November 10th. The company reported $0.01 earnings per share (EPS) for the quarter. The company had revenue of $342.90 million for the quarter, compared to analysts’ expectations of $323.66 million. Privia Health Group had a negative net margin of 3.02% and a negative return on equity of 6.82%. Sell-side analysts predict that Privia Health Group, Inc. will post -0.26 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. grew its stake in Privia Health Group by 7.1% in the 3rd quarter. Vanguard Group Inc. now owns 4,824,724 shares of the company’s stock valued at $164,331,000 after buying an additional 321,734 shares during the last quarter. BlackRock Inc. grew its stake in Privia Health Group by 16.8% in the 3rd quarter. BlackRock Inc. now owns 3,283,793 shares of the company’s stock valued at $111,846,000 after buying an additional 471,296 shares during the last quarter. Price T Rowe Associates Inc. MD grew its stake in Privia Health Group by 71.8% in the 2nd quarter. Price T Rowe Associates Inc. MD now owns 2,780,204 shares of the company’s stock valued at $80,960,000 after buying an additional 1,162,270 shares during the last quarter. FMR LLC grew its stake in Privia Health Group by 78.5% in the 2nd quarter. FMR LLC now owns 1,456,914 shares of the company’s stock valued at $42,425,000 after buying an additional 640,492 shares during the last quarter. Finally, Principal Financial Group Inc. grew its stake in Privia Health Group by 25.0% in the 2nd quarter. Principal Financial Group Inc. now owns 1,314,913 shares of the company’s stock valued at $38,290,000 after buying an additional 263,289 shares during the last quarter. Institutional investors and hedge funds own 66.83% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Truist Financial reduced their target price on shares of Privia Health Group to $41.00 in a research note on Thursday, November 17th. Piper Sandler cut their price target on shares of Privia Health Group to $42.00 in a research report on Thursday, November 17th. Stifel Nicolaus assumed coverage on shares of Privia Health Group in a research report on Thursday, December 8th. They set a “buy” rating and a $28.00 price target on the stock. UBS Group assumed coverage on shares of Privia Health Group in a research report on Thursday, December 8th. They set a “buy” rating and a $30.00 price target on the stock. Finally, BTIG Research cut their price target on shares of Privia Health Group from $45.00 to $40.00 in a research report on Monday, January 9th. Twelve research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $39.46.

Privia Health Group Company Profile

(Get Rating)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Recommended Stories

Insider Buying and Selling by Quarter for Privia Health Group (NASDAQ:PRVA)

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.